Patients’ stem cells point to potential treatments for motor neuron disease – Cosmos
Cosmos |
Patients’ stem cells point to potential treatments for motor neuron disease
Cosmos The results, published in the journal Cell Reports, comprise the most fine-grained work to date on how ALS operates on a molecular level – and suggest powerful new treatment methods based on stem cells. Indeed, so exciting are the implications of the … |
The Independent |
Immunotherapy: ‘Revolutionary’ new treatment made available to lung cancer patients on NHS for first time
The Independent Lung cancer patients in the late stages of the disease will have access to a revolutionary new treatment on the NHS for the first time. Immunotherapy – a new type of medicine that boosts the body’s immune system to fight tumours – was recommended for … Britain backs first-line use of Merck’s Keytruda under cancer fund (MRK)Markets Insider |
Nature.com |
Trials of embryonic stem cells to launch in China
Nature.com In the next few months, surgeons in the Chinese city of Zhengzhou will carefully drill through the skulls of people with Parkinson’s disease and inject 4 million immature neurons derived from human embryonic stem cells into their brains. Then they will … |
Nature.com |
Trials of embryonic stem cells to launch in China
Nature.com In the next few months, surgeons in the Chinese city of Zhengzhou will carefully drill through the skulls of people with Parkinson’s disease and inject 4 million immature neurons derived from human embryonic stem cells into their brains. Then they will … |
UCalgary News |
Promising possibilities of stem cell research explored at UCalgary event
UCalgary News Adamson and Biernaskie were among the speakers at 5th Annual StemCell Talks, a symposium organized by university students. Nearly 180 students from 15 high schools learned about current stem cell research — from cell transplants to treat chronic … |
STAT |
CRISPR stocks sank on news the gene editing tool can veer off target. But that’s hardly news
STAT A letter 1 in Nature Methods pointing out potentially dangerous flaws in the CRISPR-Cas9 genome editing system gave biotech investors a sinking feeling on Tuesday, and stocks in genome-editing companies had the same experience. By the close of trading … CRISPR Gene Editing May Cause Hundreds of Unintended Mutations in DNAFuturism CRISPR May Not Be Nearly as Precise as We ThoughtGizmodo Crack in CRISPR Facade after Unanticipated In Vivo Mutations AriseGenetic Engineering & Biotechnology News ScienceAlert –New Scientist –Siliconrepublic.com all 35 news articles » |